![](https://www.microbiometimes.com/wp-content/uploads/2020/11/shutterstock_285560891-326x245.jpg)
Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise
Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]